Starjemza's inclusion in Cost Plus Drugs' portfolio aims to challenge traditional specialty medication economics and enhance ...

Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) today announced the addition of Starjemza®, a new biosimilar medication, to its growing portfolio of affordable prescription drugs. Starjemza® ...

Mark Cuban Cost Plus adds Stelara biosimilar Starjemza, offering it at $360 per syringe to lower biologic drug costs for patients.

President Trump promised to lower the cost of Ozempic. Mark Cuban says he's working from the same playbook as Cost Plus, ...

Mark Cuban, founder of Cost Plus Drugs, is sharing access to its application programming interface so that TrumpRx can pull price data, per a healthcaredive.com report.

Giant Eagle pharmacies in western Pennsylvania and four other states have joined the Mark Cuban Cost Plus Drugs retailer network, a company co-founded in 2022 by the well-known businessman to make ...

"We're excited to partner with Mark Cuban Cost Plus Drugs, a company that shares our commitment to transparency, ...

Morris & Dickson LLC, the nation's largest independent pharmaceutical distributor, today announced a strategic partnership with Mark Cuban Cost Plus Drug Company and the Cost Plus Marketplace to ...

COLUMBIA, Mo., Sept. 11, 2025 /PRNewswire/ -- Paytient, a leader in innovative employer and insurer payment solutions that make healthcare more affordable has teamed up with Mark Cuban Cost Plus Drug ...

What inspired Shark Tank star and billionaire Mark Cuban to launch his pharmaceutical company, Cost Plus Drugs, was conversations with politicians about a contentious topic: Obamacare. "Going back to ...

Mark Cuban Cost Plus Drugs will partner with TrumpRx, the Trump administration's website where Americans can buy prescription medication at discounted prices. Cuban initially announced the partnership ...